Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
News|Articles|September 2, 2001
- Pharmaceutical Technology-09-02-2001
- Volume 25
- Issue 9
Outsourcing Outlook
Author(s)Jim Miller
The author forecasts industry mergers and acquisitions activities.
Advertisement
Articles in this issue
about 25 years ago
Six Sigma Can Give Contractors a Quality Advantageabout 25 years ago
Industry Changes OTC Labels as Deadline Approachesabout 25 years ago
A Report of the PQRI Workshop on Blend Uniformityabout 25 years ago
Are You Ready for Global Manufacturing?about 25 years ago
Pharmaceutical Coverage and CostsAdvertisement
Related to this article
Advertisement
Advertisement